Bigi, F.; Manzato, E.; Barbato, S.; Talarico, M.; Puppi, M.; Masci, S.; Sacchetti, I.; Restuccia, R.; Iezza, M.; Rizzello, I.;
et al. Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review. Pharmaceuticals 2024, 17, 944.
https://doi.org/10.3390/ph17070944
AMA Style
Bigi F, Manzato E, Barbato S, Talarico M, Puppi M, Masci S, Sacchetti I, Restuccia R, Iezza M, Rizzello I,
et al. Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review. Pharmaceuticals. 2024; 17(7):944.
https://doi.org/10.3390/ph17070944
Chicago/Turabian Style
Bigi, Flavia, Enrica Manzato, Simona Barbato, Marco Talarico, Michele Puppi, Simone Masci, Ilaria Sacchetti, Roberta Restuccia, Miriam Iezza, Ilaria Rizzello,
and et al. 2024. "Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review" Pharmaceuticals 17, no. 7: 944.
https://doi.org/10.3390/ph17070944
APA Style
Bigi, F., Manzato, E., Barbato, S., Talarico, M., Puppi, M., Masci, S., Sacchetti, I., Restuccia, R., Iezza, M., Rizzello, I., Sartor, C., Mancuso, K., Pantani, L., Tacchetti, P., Cavo, M., & Zamagni, E.
(2024). Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review. Pharmaceuticals, 17(7), 944.
https://doi.org/10.3390/ph17070944
